MyFinsight
Home
Blog
About
US
$198,605K
Non Us
$31,959K
Revenue From Contract
With Customer...
$98,125K
Pmo Products
$230,564K
Elevidys
$98,125K
Products, net
$328,689K
(-35.94%↓ Y/Y)
Collaboration and other
$72,562K
(-25.93%↓ Y/Y)
Net (loss) income
-$4,890K
(-102.48%↓ Y/Y)
Total revenues
$401,251K
(-34.34%↓ Y/Y)
Income tax expense
(benefit)
$3,141K
(107.26%↑ Y/Y)
(loss) income before
income tax expense...
-$1,749K
(-101.14%↓ Y/Y)
Operating income (loss)
$13,291K
(-88.50%↓ Y/Y)
Total cost and
expenses
$387,960K
(-21.71%↓ Y/Y)
Other (expense)
income, net
-$15,040K
(-139.52%↓ Y/Y)
Cost of sales
(excluding amortization of...
$149,385K
(-2.08%↓ Y/Y)
Selling, general and
administrative
$107,600K
(-21.97%↓ Y/Y)
Research and development
$91,258K
(-55.35%↓ Y/Y)
Litigation contingency
charge
$39,000K
Amortization of in-licensed
rights
$717K
(7.50%↑ Y/Y)
Back
Back
Income Statement
logo (1) copy-svg
Sarepta Therapeutics, Inc. (SRPT)
logo (1) copy-svg
source: myfinsight.com
Sarepta Therapeutics, Inc. (SRPT)